Director of Market Access & Pricing
Prunelle GAUGY is Director of Market Access & Pricing at CEMKA. She supports pharmaceutical, biotech and medical device companies in defining and implementing market access, pricing and reimbursement strategies throughout the product lifecycle.
Since joining CEMKA in 2018, she has contributed to the launch and market access of numerous healthcare products across a wide range of therapeutic areas, including oncology, hematology, rare diseases and digital health. She advises clients on HTA strategies, pricing and reimbursement submissions, interactions with health authorities and price negotiations.
As Director, she leads high-impact projects combining regulatory and market access analyses, strategic vision and project team coordination.
She has developed recognized expertise in digital medical devices (DMDs), particularly in remote monitoring and digital therapeutics, and serves as reference for the team in this field.
Prunelle GAUGY holds a Doctorate in Pharmacy (University of Dijon) and a Master’s degree in Health Economics and Management (Paris Dauphine University).
